This comprehensive review systematically synthesizes clinical and basic research progress in elucidating the complex relationship between obesity and CVDs and discusses future research directions, including precision medicine, exploration of novel therapeutic targets, and single-cell spatiotemporal omics.
Abstract
Obesity, given its strong association with cardiovascular diseases (CVDs), is a major global public health issue attracting increasing attention. This comprehensive review systematically synthesizes clinical and basic research progress in elucidating the complex relationship between obesity and CVDs. We explore the epidemiology, pathophysiology, clinical manifestations, and management strategies for obesity-related CVDs. Drawing on recent studies, we highlight the effects of obesity on atherosclerotic disease, cardiomyopathy, heart failure, arrhythmias, hypertension, and venous thromboembolism. Understanding these mechanisms is essential for developing effective prevention and treatment strategies to decrease the cardiovascular burden associated with obesity. Furthermore, this review summarizes current therapeutic approaches for obesity-related CVDs, such as lifestyle interventions, pharmacotherapy, and metabolic surgery, and discusses future research directions, including precision medicine, exploration of novel therapeutic targets, and single-cell spatiotemporal omics.
The findings support the implementation of patient centered models of care that integrate individualized pharmacological treatment, sustainable lifestyle modifications, health education, continuous clinical follow up, and multidisciplinary healthcare teams to optimize blood pressure control, reduce cardiovascular compl...
This review examines aspects of CVH that are commonly managed in preventive cardiology programs, focusing on diagnostic evaluation and treatment strategies, highlighting new and emerging therapies for children and adolescents, including pharmacotherapy and latest research on effective lifestyle modifications.
M. Degen, Shannon M. Lyon· Current opinion in pediatric...· 0 citations
Cardiovascular diseases (CVDs) are characterized by high morbidity and mortality rates. Recent studies highlight the significance of epicardial adipose tissue (EAT) in the pathophysiology of coronary artery disease (CAD), arrhythmias, and heart failure (HF), primarily through its direct effects on cardiac structure and...
Jing Zhang, Ziyu An, Hanzhong Luo et al.· The Journal of Cardiovascula...· 0 citations
Cardiovascular disease (CVD) is the leading cause of death and disability globally. Thus, prevention efforts aimed at reducing CVD events allow for greater functional independence and wellbeing over the course of life. Low-density lipoprotein-cholesterol is causally associated with atherosclerosis and is the primary ta...
R. Rikhi, Michael D. Shapiro· Progress in cardiovascular d...· 0 citations
Comorbidity, defined as the coexistence of multiple chronic diseases, has become a major concern in global healthcare. Among the clinically significant comorbid conditions, diabetes mellitus, hypertension, and liver disease, particularly non-alcoholic fatty liver disease (NAFLD), represent a complex and interrelated pa...
Jeewanjot Singh, Prabhjot Singh, Subhi Sharma· Gene & Protein in Diseas...· 0 citations
Background. Chronic inflammatory diseases are increasingly recognized as important contributors to cardiovascular morbidity and mortality. Persistent systemic inflammation, endothelial dysfunction, and accelerated atherosclerosis contribute to cardiovascular complications in autoimmune and chronic inflammatory disorder...
Zuzanna Rak, A. Wielogórska, K. Dzień et al.· International Journal of Inn...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.